April 1, 2026

Science Chronicle

A Science and Technology Blog

April 1, 2026

Science Chronicle

A Science and Technology Blog

Month: January 2021

CoronavirusIndiaPublic HealthSARS-CoV-2Vaccines

Reneging on the ‘no-profit pledge’ to supply Oxford vaccine

On the say day the release was sent out announcing the partnership with AstraZeneca, Oxford University also tweeted saying that the

Read More
CoronavirusIndiaPublic HealthSARS-CoV-2Vaccines

With more vaccines than vaccinations, India exports Covishield before expiry date

It is true that while the U.S. took 10 days to breach the one-million mark and the U.K. took 18

Read More
CoronavirusICMRPublic HealthSARS-CoV-2Vaccines

Study finds Covaxin effective against the UK variant

The sera from people vaccinated with Covaxin were tested against the same strain used for making the vaccine, another strain

Read More
CoronavirusPublic HealthSARS-CoV-2Vaccine hesitancyVaccines

Glitches in CoWIN also responsible for low COVID-19 vaccine uptake

On January 16, the first day of COVID-19 vaccination in the country, at about only 1.91 lakh health-care workers taking

Read More
Clinical trialCoronavirusPublic HealthSARS-CoV-2Vaccines

Indian scientists divided over restricted use approval for Covaxin

In a tweet on January 14, the Health Ministry said both Covishield and Covaxin approved for restricted use by the

Read More
Clinical trialCoronavirusPublic HealthSARS-CoV-2Vaccine hesitancyVaccines

Vaccine dilemma: To take or not to take Covaxin

True, in the U.S., vaccines from both Pfizer and Moderna are available and recipients, who are health-care workers and nursing

Read More
Clinical trialCoronavirusCOVID-19ICMRPublic HealthSARS-CoV-2Vaccines

Serious violations in Covaxin trial in Bhopal show nothing has changed since the egregious HPV vaccine trial

The phase-3 clinical trial of Bharat Biotech’s COVID-19 vaccine, Covaxin, by a private hospital in the Bhopal-based Peoples College of

Read More
Clinical trialCoronavirusCOVID-19IndiaPublic HealthSARS-CoV-2Vaccines

New challenges in conducting COVID-19 vaccine trials in India

The Ahmedabad-based Zydus Cadilla only recently got the regulatory permission to carry out phase-3 trial and has to begin the

Read More
Clinical trialCoronavirusCOVID-19Public HealthSARS-CoV-2Vaccine hesitancyVaccines

I would not take Covaxin without efficacy data: Gagandeep Kang

Scientists, manufacturers and drug regulators have been speeding up the timelines to develop, test and approve vaccines for emergency use.

Read More
Avian influenzaHealthPublic Health

Stamp out the avian influenza virus quickly

While avian influenza virus crossing the species barrier and directly infecting humans happens only occasionally, human-to-human spread has been rare and not sustained. But mutations in the virus or genetic reassortment could likely result in sustained transmission between humans thus increasing the risk of a pandemic influenza.

Read More
CoronavirusCOVID-19Public HealthSARS-CoV-2

Can the lockdown in England control new variant spread?

As on December 4, U.K has reported 2.7 million cases and over 75,500 deaths, the second highest death toll in

Read More
Clinical trialCoronavirusCOVID-19IndiaPublic HealthSARS-CoV-2Vaccines

With hasty approval, India squanders an opportunity to build trust in COVID-19 vaccine

Transparency in the approval process is vital for gaining the trust of people so that they don’t hesitate to take

Read More
Clinical trialCoronavirusCOVID-19Public HealthSARS-CoV-2Vaccines

Why people with prior SARS-CoV-2 infection still need to be vaccinated

Since vaccine shortage is expected to last at least for a few months, it may seem appealing to delay or

Read More